Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Bobthebuilddron Jan 08, 2017 4:10pm
79 Views
Post# 25680951

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just some food for thought

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just some food for thought Cgc DOES NOT depend on full recreational market to survive. Not by a long shot which multiple posters have shown with statistics. You have shown nothing but a shorters view. How many companies out there have a market cap of billions+ and make less then 100 million? Or have a market cap of 10 billion and make less revenue then 1 billion? By the end of 2017, CGC will be 100% green in revenue and then some. Earning between 100 - 150million COMPLETELY on medical sales. Try as you will Brent. You have no facts at all to back up anything you ever post. You're time to be wrong is slowly approaching. I'm pretty sure whatever the SP is, you want in at a 30% discount. Just like Chemdog.
brentkosta wrote:
YodaLayhehoo wrote:
Put your capital into APH to help them grow their production, so they can compete for the remaining 50% of the market with the other small fries, or put your capital into a company that is already built out more capacity and is using it to produce revenue for the company? Common sense


Quesiton:

When institutional investors dive in. Are they going to invest in a company that depends on full legal reform to allow them to stay afloat? 

OR invest in..

A company that has best margins, profits q after q, can scale up cheaper than anyone else and the CEO has years of experience in health and wellness. 





Bullboard Posts